Pluri (PLUR) Cash & Equivalents Growth (3y) (2013 - 2025)
Pluri (PLUR) Cash & Equivalents Growth (3y) (2013 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash & Equiv. Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
24.73% |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
-40.88% |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
-28.55% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
21.66% |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
-16.07% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Pluri |
20.93 Mn |
21.41 Mn |
86,000.00 |
-22.74% |
| Date | Value |
|---|
| Dec 31, 2025 |
-22.74% |
| Sep 30, 2025 |
-24.84% |
| Jun 30, 2025 |
-19.77% |
| Mar 31, 2025 |
-30.14% |
| Dec 31, 2024 |
-27.82% |
| Sep 30, 2024 |
-40.55% |
| Jun 30, 2024 |
-40.27% |
| Mar 31, 2024 |
-52.36% |
| Dec 31, 2023 |
-6.06% |
| Sep 30, 2023 |
-7.44% |
| Jun 30, 2023 |
-8.88% |
| Mar 31, 2023 |
88.34% |
| Dec 31, 2022 |
161.14% |
| Sep 30, 2022 |
161.34% |
| Jun 30, 2022 |
40.60% |
| Mar 31, 2022 |
228.54% |
| Dec 31, 2021 |
175.83% |
| Sep 30, 2021 |
21.75% |
| Jun 30, 2021 |
259.19% |
| Mar 31, 2021 |
131.71% |
